Protocol GLI.04.US.SL.017 CONFIDENTIALInvestigator Agreement • May 2nd, 2023
Contract Type FiledMay 2nd, 2023Title A multi-center, prospective pilot study on safety and effectiveness of a healing ointment as a post-surgical care Protocol number: GLI.04.US.SL.017 Sponsor name and address: Galderma Laboratories, L.P. 14501 North FreewayFort Worth, TX 76177 USA Test product: Cetaphil® Healing Ointment Investigator agreement: I have read the clinical study described herein, recognize its confidentiality, and agree to conduct the described study in compliance with Good Clinical Practices (GCP), the ethical principles contained within the Declaration of Helsinki, this protocol, and all applicable regulatory requirements. Principle Investigator: Signature Date Name: Aaron Farberg, MD Address: Derm Texas2110 Research RowDallas, TX 75235 USATelephone: (214) 845-6426 Legacy Dermatology 3140 Legacy Dr., #110Frisco, TX 75034 USATelephone: (972) 787-0010